The legacy success of Viagra has undeniably transformed the healthcare landscape. However, putting money in companies heavily focused on biosimilars and the diminishing patent protection surrounding this blockbuster medication presents a significant degree of peril . While leading pharma firms can still profit from related products , the net out… Read More

The emergence of so-called "Elite Gambler's Viagra" – often referring to exceptionally high doses ordered by disreputable physicians – represents a troublingly alarming trend. While common dosages of Sildenafil are intended for treating erectile dysfunction safely in most men, these significantly elevated amounts pose a serious hazard to cardio… Read More